LONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE
(University of London)
FACULTY OF INFECTIOUS AND TROPICAL DISEASES
DEPARTMENT OF IMMUNOLOGY AND INFECTION
RESEARCH FELLOW
We are seeking to appoint a post doctoral research fellow to study the T cell
mediated immune response to Burkholderia pseudomallei.
The successful applicant will hold a PhD in the field of melioidosis immunology and
have proven experience of immunological research in murine models of this infection
under current CDC/NIH and UK biocontainment regulations.
The post is funded by NIH for a period of 2 years and 9 months approximately and is
available from 1st June 2011 approximately. Salary is on the Academic Pathway
Grade 6 scale at £35,511 per annum inclusive.
Applications should be made on-line via our website at http://jobs.lshtm.ac.uk The
reference for this post is GB02. Applications should also include a CV and the
names and email contacts of 2 referees who can be contacted immediately if
shortlisted. Any queries regarding the application process may be addressed to
jobs@lshtm.ac.uk.
The London School of Hygiene & Tropical Medicine is committed to being an equal
opportunities employer
2.
GENERAL INFORMATION
The London School of Hygiene & Tropical Medicine
The London School of Hygiene & Tropical Medicine is one of Europe’s leading
Schools of Public Health and a leading postgraduate institution worldwide for
research and postgraduate education in global health.
Part of the University of London, the London School is the largest institution of its
kind in Europe with a remarkable depth and breadth of expertise encompassing
many disciplines. The School was ranked one of the top 3 research institutions in the
country in the Times Higher Education’s 'table of excellence', which is based on the
2008 Research Assessment Exercise (RAE), ahead of the London School of
Economics, Oxford, Imperial and University College, London. The institution also
achieved the largest increase in ranking compared with 2001, of any of the top 10
institutions in the RAE rankings. In 2009, the School became the first UK institution to
win the Gates Award for Global Health.
The School’s environment is a rich multicultural one: there are almost 4000 students
from 100+ countries following 22 taught masters courses delivered either in London
(~650) or through distance learning (~2700), and undertaking research degree
training (~400). Over 40% of these students are from non-European countries. The
largest growth has been in distance learning students (>40% over 3 years), though
the London-based student population (where accommodation limits growth) is at its
highest level ever. Alumni are working in more than 180 countries. The School has
about 1400 staff drawn from over 60 nationalities.
There are research collaborations with over 100 countries throughout the world,
utilizing our critical mass of multidisciplinary expertise which includes clinicians,
epidemiologists, statisticians, social scientists, molecular biologists, immunologists,
ophthalmologists, anthropologists, virologists, pharmacologists and nutritionists. At
any one time around 100 School staff are based overseas, particularly in Africa and
Asia. We have a strong commitment to partnership with institutions in low and middle
income countries to support the development of teaching and research capacity.
The School has expanded greatly in recent years. Its research funding now exceeds
m£62.4 per annum, much of it from highly competitive national and international
sources. The commitment of staff to methodological rigour, innovative thinking and
policy relevance will ensure that the School continues to occupy a leadership position
in national and global health, adapting quickly to new challenges and opportunities.
Mission
The School's mission is to contribute to the improvement of health worldwide
through the pursuit of excellence in research, postgraduate teaching and
advanced training in national and international public health and tropical
medicine, and through informing policy and practice in these areas."
Faculty of Infectious and Tropical Diseases
The Faculty of Infectious and Tropical Diseases encompasses all of the laboratorybased research in the School as well as that on the clinical and epidemiological
aspects of infectious and tropical diseases. It is headed by Simon Croft, who is
Professor of Parasitology. The range of disciplines represented in the faculty is very
broad and inter-disciplinary research is a feature of much of our activity. The
spectrum of diseases studied is wide and there are major research groups with a
focus on malaria, tuberculosis, HIV/AIDS and other sexually transmitted diseases,
vaccine development and evaluation, and vector biology and disease control. The
Faculty is organised into four large research departments comprising: Pathogen
Molecular Biology, Immunology and Infection, Disease Control, and Clinical
Research. There is close interaction between scientists in different research teams.
The Faculty has strong overseas links, which provide a basis for field studies and
international collaborations in developed and developing countries. The teaching
programme includes MSc courses, taught in-house and by distance learning, which
are modular in structure, a variety of short-courses and an active doctoral
programme (PhD and DrPH).
Department of Immunology and Infection (Head: Professor Eleanor Riley)
Research in the Department of Immunology and Infection centres on analysis of the
host response to infection at the molecular, cellular and population levels. The goals
are to develop a greater understanding of basic mechanisms of immunological
protection versus pathology, and to apply this knowledge to the development of
immunological interventions and the identification of correlates of immune status. Our
work involves application of state-of-the-art cellular and molecular approaches to the
in vitro analysis of pathogen-host cell interactions, to in vivo studies in models and to
the study of immunity at the population level in disease endemic areas. Main areas of
research include the regulation of acute and chronic inflammation; macrophagepathogen interactions; cellular pharmacology; the production of cytokines during
innate and acquired immune responses; T-cell function and antigen recognition; the
mechanisms of immunopathology; the development of vaccines; and delivery
systems for vaccines and drugs.
Current research includes the role of acute phase proteins in resistance to infection,
homeostasis and inflammatory disease, mechanisms of macrophage activation,
control of cytokine synthesis and mammalian lectin interactions (J. Raynes);
intracellular trafficking and secretory pathways of cells of the immune system (T.
Ward); the role of innate responses in resistance to the bacterial pathogens,
Mycobacterium tuberculosis and Burkholderia pseudomallei, activity and regulation of
natural killer cells and their effect on macrophage activation and recruitment,
regulation of chemokine receptors during infection and granulomatous tissue
responses in the lung against Cryptococcus neoformans and Mycobacterium
tuberculosis (G. Bancroft); correlates of protection against tuberculosis and studies of
BCG vaccination, human CD8+ T-cell responses to mycobacterial antigens and
synthetic peptides, use of whole blood assays in immuno-epidemiology (H. Dockrell);
cytokine and chemokine responses to leprosy, cellular composition and effects of
steroids on skin and nerve lesions of reactional leprosy, identification of specific
peptides for immunodiagnosis of leprosy (S. Young); innate and adaptive immunity to
malaria including activation of natural killer cells, cytokine regulation in clinical
immunity and immunopathology, regulation of antibody production and
immunoglobulin class switching (E. Riley); using anti-malarial antibodies as a marker
of malaria exposure & assessment of the use of sero-epidemiology to monitor and
target malaria control measures www.seromap.com (C. Drakeley)transmission of
Plasmodium falciparum malaria including antibody responses to gametocyte-infected
erythrocyte surface antigens, effect of gamete antigen variability on transmission,
gametocyte sequestration and development and gametocyticidal drug therapy (C.
Sutherland); characterisation of protective immune mechanisms and defined
antigens in attenuated vaccine models of schistosomiasis (Q. Bickle); impact of
concomitant viral, bacterial, protozoal and helminth infections on induction of immune
responses and immunopathology and T cell regulation and induction of mucosal
immune responses during intestinal nematode infections (H. Helmby); the
identification and evaluation of novel drugs and drug delivery systems for
leishmaniasis, trypanosomiasis and malaria, interaction between antiprotozoal drugs
and the immune response (L. Vivas, V. Yardley)
Department of Pathogen Molecular Biology (Head: Professor John Kelly)
Research in the Department of Pathogen Molecular Biology focuses on the molecular
biology and genetics of pathogens and their hosts in the context of improving the
understanding and control of infectious diseases. Aspects of pathogen biology of
interest include: (i) determining the mechanisms of infection of globally important
viral, bacterial and parasitic pathogens; (ii) deciphering the genetic diversity of
selected disease agents in natural populations and to determine its epidemiological
impact, (iii) studying immune evasion mechanisms of particular disease agents, (iv)
exploiting parasitic, bacterial and viral pathogens as model biological systems and (v)
developing practical applications including improved diagnostic tests and the
identification and characterisation of vaccine candidates and drug targets.
PMBD currently has funding to investigate, amongst others, the malaria parasite
(Plasmodium spp), Chagas disease (Trypanosoma cruzi), African sleeping sickness
(Trypanosoma brucei), amoebic dysentery (Entamoeba), the Leishmania species,
bacterial food borne pathogens (Campylobacter jejuni and Yersinia enterocolitica),
gastric ulcers/cancer (Helicobacter pylori), pseudomembranous colitis (Clostridium
difficile), plague (Yersinia pestis), paddy field melioidosis (Burkholderia
pseudomallei), Tuberculosis (Mycobacterium tuberculosis), Pneumonia
(Streptococcus pneumoniae), Bluetongue viral disease of livestock, Herpesviridae,
SARS, the hemorrhagic fever virus (RVFV) and the enteric rotavirus that cause
significant diarrhoeal disease in infants developing countries.
The long-term aim of PMBD research is to gain a fully rounded understanding of the
complex and dynamic ways by which pathogens modulate virulence and interact with
the human host. Such a holistic approach will vastly increase the scope for the
rational of design of long-term intervention strategies to reduce the burden of
infectious disease. In recent years such a mission has been significantly enhanced
by the availability of whole genome sequences. Members of the Department are, or
have been, involved in several pathogen genome projects including Herpes,
Campylobacter jejuni, Yersinia pestis, Clostridium difficile, Entamoeba and
Trypanosome species. In particular, post genome studies have facilitated research
on more complex parasites such as Plasmodium, Entamoeba and Trypanosome
species. The interpretation and exploitation of this basic information is the platform
for numerous new avenues of research on pathogenesis, epidemiology and the
evolution of virulence.
Department of Clinical Research (Head: Prof Alison Grant)
The Department of Clinical Research addresses infectious diseases of major public
health importance in developing countries. Activities include trials of new therapies,
vaccines and educational interventions; the development of new diagnostic tests;
studies to elucidate the immunological and molecular correlates of pathogenesis and
protective immunity, and to identify genetic polymorphisms conferring protection or
susceptibility to infectious diseases; health services research which aims to identify
the most efficient and cost-effective way to deliver health care; and health policy
analysis. In addition to our many overseas collaborations, we have close links with
the Hospital for Tropical Diseases, in new, purpose-built accommodation on the main
UCL Hospital campus, five minutes walk from the School. The Wellcome Trust
Bloomsbury Centre for Clinical Tropical Medicine is based in the Department, and
currently supports five Clinical Training Fellows and two Career Development
Fellows, most of whom are based overseas.
Much of the Department’s research concerns HIV and related infections; in particular,
the interaction between HIV infection and other sexually transmitted diseases, and
between HIV infection and tuberculosis. We have longstanding and fruitful
collaborations addressing these issues in Tanzania, Zambia, Uganda and South
Africa. Brian Greenwood FRS is leading an initiative to strengthen malaria research
in the School through new collaborative links in Africa. Research and teaching on
blinding diseases in developing countries has been greatly strengthened by the
recruitment of Allen Foster, who is Medical Director of CBM International, an NGO
with programmes for the prevention of blindness and disability in over 100 countries;
our research on trachoma has played an important part in framing the strategies
adopted by the WHO and the new International Trachoma Initiative for the elimination
of blinding trachoma by the year 2020.
Department of Disease Control (Head: Dr Mark Rowland)
This multidisciplinary Department includes epidemiologists, entomologists,
anthropologists and social scientists, clinical scientists, public health engineers, and
geographers. This range of expertise provides us with a battery of tools for focusing
on the control of diseases that are insect-borne, water-borne or associated with poor
hygiene – mostly in developing countries. Much of the research can be categorised
as: evaluating disease control interventions; investigating implementation strategies including working with the private sector; understanding the factors underlying
household behaviour in relation to family health; or determining how control
resources can be targeted most efficiently. Particular attention is paid to research
directed at current health policy issues, including the gap between policy and
practice. The DFID Resource Centre for Water and Environmental Health (WELL)
and the Hygiene Centre make up the Department’s Environmental Health Group,
which plays a leadership role in research and operational support for hygiene
promotion, water supply and sanitation. The Department also houses the largest
research group in LSHTM working on malaria control, including the DIFD Team for
Applied Research to Generate Effective Tools and Strategies for communicable
disease control (TARGETs) and the Malaria Capacity Development Consortium
(MCDC). The Department’s valuable mosquito colonies are used for testing repellent
products and insecticides in the laboratory. The Department also includes a major
grouping of researchers using spatial analysis in public health.
Teaching
The School offers 22 one year full-time taught courses leading to the Master of
Science (MSc) degree of the University of London and the Diploma of the London
School of Hygiene and Tropical Medicine (DLSHTM). The Faculty of Infectious and
Tropical Diseases runs or contributes substantially to ten of these courses and the
“Immunology of Infectious Diseases” course is run from within the Department of
Immunology and Infection. In addition, the Faculty is responsible for the three-month
Diploma in Tropical Medicine and Hygiene (DTM&H) and offers a range of specialist
short courses lasting usually one or two weeks. Three MSc courses are also offered
by Distance-based Learning, including one on Infectious Diseases.
Research Training
The School offers two doctoral training programmes. The MPhil/PhD degrees are
designed for those who wish to go on to a full time research career. The DrPH is
directed towards those who expect their careers to be more in the practice of public
health.
Project information
Burkholderia pseudomallei (Bp), is a Gram negative bacterium that causes
melioidosis which is a major cause of sepsis in regions of Southeast Asia and
Northern Australia. This being a disease which is hard to diagnose and can be
rapidly fatal, there is an urgent, unmet need for better diagnostics, vaccine strategies
and therapies. In light of current interest in T cell subsets and effector cytokines in
microbial immunity, we will identify epitopes that are specifically seen by T cells
during infection.
3.
JOB DESCRIPTION
Post:
Research Fellow
Grade:
Academic Pathway Grade 6
Responsible to:
Dr GJ Bancroft
Department:
Immunology and Infection
Main duties and responsibilities:
The successful candidate will work in the Department of Immunology and Infection
and will be responsible to the Grant Holder (Dr. GJ Bancroft) and the Head of
Department (currently Prof. E Riley).
The successful candidate will:




●
●


4.
Conduct an individual research programme on the T cell mediated immune
response to B. pseudomallei vaccination under the direct supervision of the Grant
Holder.
Take an active role in collaborative studies within and external to the Faculty.
Play an active role in laboratory and departmental scientific meetings and journal
clubs
Participate in general laboratory duties as designated by the Grant Holder
To contribute to the Faculty teaching programme, up to 10% of your time
per annum, subject to the policy of any funding agency (by agreement,
some staff may make a greater contribution than this).
Play an active part in the academic life of the School and participate in
departmental and faculty activities
Maintain adequate records of experimental work
Any other reasonable duties as requested by the Grant Holder or Head of Faculty
PERSON SPECIFICATION
Essential:
 Have experience in immunological research involving murine models of B.
pseudomallei under CDC/NIH Select Agent regulations as applied within the
UK
 Extensive experience in murine vaccine studies in B. pseudomallei,
particularly in the role of T cells and their subsets in these responses.
 Have a PhD in the T cell immunology of Burkholderia infections in murine
models
 Have a UK Home Office personal license with experience in intranasal dosing
Desirable:
 Proven ability to teach new staff practical skills in Category 3 procedures in
relation to B. pseudomallei protocols
5.
SALARY AND CONDITIONS OF APPOINTMENT
The post is funded by NIH for a period of 2 year and 9 months approximately and is
available from 1st June 2011 approx. Salary is on the Academic Pathway Salary
Grade 6 scale at £35,511 per annum inclusive. Annual leave entitlement is 30
working days per year for all staff (pro-rata for part-time staff). In addition to this
there are 6 fixed-date "Director's Days".
6.
APPLICATIONS
Applications should be made on-line via our website at jobs.lshtm.ac.uk. The
reference for this post is GB02. Online applications will be accepted by the
automated system until midnight of the closing date. Any queries regarding the
application process may be addressed to jobs@lshtm.ac.uk or telephone 0207 927
2361.
The supporting statement section should set out how your qualifications, experience
and training meet each of the selection criteria. Please provide one or more
paragraphs addressing each criterion. The supporting statement is an essential part
of the selection process and thus a failure to provide this information will mean that
the application will not be considered. An answer to any of the criteria such as
“Please see attached CV” will not be considered acceptable.
Please note that if you are shortlisted and are unable to attend on the interview date
it may not be possible to offer you an alternative date.
The London School of Hygiene & Tropical Medicine is committed to being an equal
opportunities